服用选择性5-羟色胺再摄取抑制剂时出现盗汗和促卵泡激素水平升高。
Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors.
作者信息
Shahine Lora K, Lathi Ruth B
机构信息
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco, CA 94143-0132, USA.
出版信息
Obstet Gynecol. 2006 Sep;108(3 Pt 2):741-2. doi: 10.1097/01.AOG.0000189718.07777.c1.
BACKGROUND
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to women with depression and anxiety disorders. Although night sweats are a reported adverse effect, some women have relief of vasomotor symptoms during perimenopausal period while taking them. The relationships between SSRIs, thermoregulation, gonadotropins, and estrogen and their connection to fertility remain unclear.
CASE
A reproductive-aged woman, seeking treatment for infertility, experienced night sweats and elevated follicle-stimulating hormone levels while taking SSRIs for treatment of depression.
CONCLUSION
Many women of reproductive age are taking SSRIs, but the affect of SSRIs on normal reproductive function is unknown and further research in this area is needed.
背景
选择性5-羟色胺再摄取抑制剂（SSRIs）常用于治疗患有抑郁症和焦虑症的女性。尽管盗汗是一种已报道的副作用，但一些女性在围绝经期服用这些药物时血管舒缩症状有所缓解。SSRIs、体温调节、促性腺激素、雌激素之间的关系及其与生育能力的联系仍不清楚。
病例
一名育龄妇女因不孕症寻求治疗，在服用SSRIs治疗抑郁症期间出现盗汗和促卵泡生成素水平升高。
结论
许多育龄女性正在服用SSRIs，但SSRIs对正常生殖功能的影响尚不清楚，这一领域需要进一步研究。
Zotero 插件